|
|
|
|
Office Locations:
|
780 Third Avenue, 43rd Floor
New York, NY 10017
Phone: 212-319-4633
Fax: 212-319-4639
| |
|
|
|
|
|
|
Consumer Products & Services
Financial Services
Information Technology
Life Sciences & Healthcare
Software & Internet
|
|
|
|
Baillie Gifford was established as an investment management partnership over 110 years ago. manages and advises US$ 445.3bn in specialist equity, fixed income and multi-asset portfolios for a global client base. The firm's geographical exposure also encompasses professional investor clients in Australia, Singapore, Hong Kong, China, Thailand, Korea, the Middle East and South Africa. Baillie Gifford today is wholly owned by its 46 partners, all of whom work within the firm. Baillie Gifford Schiehallion Fund (MNTN) is a closed-end investment company dedicated to the unlisted 'unicorns' that its flagship Scottish Mortgage Trust (SMT) has successfully pioneered.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
|
| Name | |
| |
Title | |
|
| Mark Urquhart | |
| |
Senior Investment Manager | |
| Peter Singlehurst | |
| |
| |
| Spencer Adair | |
| |
| |
|
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
11/13/2025
|
goPuff
|
PA
|
$250,000,000
|
Venture
|
11/13/2025
|
Carbon3D
|
CA
|
$60,000,000
|
Venture
|
09/04/2025
|
Enveda Biosciences
|
CO
|
$150,000,000
|
Series D
|
08/21/2025
|
Nuro
|
CA
|
$203,000,000
|
Series E
|
06/12/2025
|
Meter
|
CA
|
$170,000,000
|
Series C
|
05/09/2025
|
Rippling
|
CA
|
$450,000,000
|
|
04/22/2025
|
Altruist
|
CA
|
$152,000,000
|
Series F
|
04/03/2025
|
Runway
|
NY
|
$308,000,000
|
Series D
|
12/02/2024
|
Tenstorrent
|
CA
|
$693,000,000
|
Series D
|
11/21/2024
|
Enveda Biosciences
|
CO
|
$130,000,000
|
Series C
|
|
|
|
|
|
|
|
